Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04336241
Title Study of RP2 Monotherapy and RP2 in Combination With Nivolumab in Patients With Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Replimune Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries GBR | ESP


No variant requirements are available.